Categories: News

Glucose Health, Inc. Appoints Veteran Financial Executive Edmund “Ned” Burke to Its Board of Directors

BENTONVILLE, Ark., Oct. 27, 2025 (GLOBE NEWSWIRE) — Glucose Health, Inc. (OTC: GLUC) is pleased to announce the appointment of Edmund (Ned) Burke, a highly accomplished financial services executive, to its Board of Directors. With more than four decades of experience at prominent investment firms, including Pioneer Funds and Fidelity Investments, Mr. Burke brings exceptional financial acumen and strategic insight to the company’s leadership team.

Mr. Burke most recently served as Chief Executive Officer of ALPS Holdings, Inc., where he played a pivotal role in the successful distribution and administration of closed-end funds, open-end funds, and exchange-traded funds (ETFs). Under his direction, ALPS expanded its services to include critical back-office solutions for many of the nation’s top money management firms. During his tenure, Mr. Burke established and managed key relationships with notable organizations, including Select Sector SPDR Exchange Traded Funds, GE Investment Management, and Clough closed-end funds.

His outstanding contributions to the financial services industry were recognized in 2016 when he received the NOVA Award from the National Investment Company Service Association, honoring his leadership and innovation in the securities sector.

As CEO, Mr. Burke oversaw impressive growth at ALPS, expanding the firm’s revenue from $15 million to $225 million from 2005 to 2019, representing a compound annual growth rate of 19.79% over approximately 15 years. In 2005, he and his team successfully negotiated the sale of ALPS to Lovell Minnick Partners, a private equity firm specializing in financial services investments. Later, in 2011, DST Systems, Inc. acquired ALPS after Mr. Burke and his team had firmly established it as a leading player in the financial services industry. Mr. Burke retired from ALPS in June 2019

Mr. Burke’s extensive experience in building and scaling financial organizations will be invaluable as Glucose Health, Inc., continues to expand operations and enhance shareholder value. In addition to his new Board role at Glucose Health, Mr. Burke serves on the mutual fund boards of several prominent money management firms, including Financial Investors Trust, ALPS ETF Trust, Clough Funds, and Liberty All-Star Trust.

Commenting on the appointment, Mark Schaftlein, CEO of Glucose Health, stated:

“Ned is an outstanding addition to our Board of Directors. His business experience and proven success in building high-performing organizations will be instrumental as we continue to advance Glucose Health’s growth strategy. As one of our largest shareholders, Ned’s interests are perfectly aligned with those of our broader shareholder base, and I look forward to working closely with him to achieve our long-term objectives.”

Mr. Burke earned a Bachelor of Arts degree in Economics from the University of New Hampshire.

CONTACT: Contact:
Investor Relations
info@glucosehealthinc.com
www.glucodown.com
www.fiberup.com
OTC: GLUC

Staff

Recent Posts

Kanazawa University research: High-speed AFM imaging reveals how brain enzyme forms dodecameric ring structure

KANAZAWA, Japan, Dec. 26, 2025 /PRNewswire/ -- Scientists at the Nano Life Science Institute (WPI-NanoLSI), Kanazawa…

2 hours ago

Arspura Showcases a New Standard for Healthy Kitchen Living at CES 2026

LOS ANGELES, Dec. 25, 2025 /PRNewswire/ -- From January 6–9, 2026, visitors can experience Arspura's…

8 hours ago

XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

RAMAT GAN, ISRAEL, Dec. 24, 2025 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the…

17 hours ago

Relapse Risk Increases During the Holidays; Desert Hope Treatment Center Urges Early Support

LAS VEGAS, Dec. 24, 2025 (GLOBE NEWSWIRE) -- This holiday season, addiction experts at Desert Hope…

17 hours ago

Profound Medical Corp. Announces Upsize of Private Placement

TORONTO, Dec. 24, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the…

17 hours ago